May 5, 2021 | Terry's Hot Takes
Greetings and May the 4th be with you! Terry’s Hot Take is a monthly resource for lawmakers by the Executive Director of Patients Rising, on behalf of the 133 million Americans living with chronic disease. H.R. 3 Includes Price Controls that will Crush Chronic and...
May 4, 2021 | Letters Supported
The undersigned organizations are writing, in anticipation of the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act (i.e., H.R. 3), to urge Congress to keep any international reference pricing proposals (including “International Pricing...
May 4, 2021 | Letters Supported
Patient groups, advocates, and providers have seen disturbing media reports about Cigna’s recent letter to patients and providers regarding the use of Cosentyx. In the letter, patients are encouraged to switch to a Cigna-preferred drug, as Cosentyx was removed from...
May 1, 2021 | Featured, Podcast
S2:EP17 | Organ Transplants and Financial Strain On this episode of the podcast, Terry and Bob discuss the hurdles that organ recipients face, particularly in their postoperative treatment, which requires them to relocate close to the specialized medical centers...
Apr 30, 2021 | Virtual Advocacy Chat
Virtual Advocacy Chats Wednesday Wake Up and Afternoon Tea Time – with Joelle...
Apr 26, 2021 | COVID-19, Featured, Federal Issues
On this episode of the podcast, Terry and Bob discuss the Food and Drug Administration and its lessons learned from the pandemic. They highlight how best practices from Operation Warp Speed and research on Covid-19 long haulers can inform ongoing treatments for those...
Apr 22, 2021 | Press Releases
April 22, 2021 Contact: Summer Johnson Sjohnson@riesterpublicaffairs.com 202.421.9216 PATIENTS RISING STATEMENT ON H.R.3 WASHINGTON, DC — Terry Wilcox, Executive Director of Patients Rising, today released the following statement in response to today’s introduction...
Apr 19, 2021 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the recent recommendations by the Medicaid and CHIP Payment and Access Commission (MACPAC) that threaten patient access to medications that have received the FDA’s accelerated approval designation. These...
Apr 16, 2021 | Federal Issues, Health Policy
By Surabhi Dangi-Garimella, Ph.D. Following the announcement of a Special Enrollment Period in the health insurance marketplace from February 15 to May 15 for those who may have lost employer-sponsored insurance during the COVID-19 pandemic, the Biden administration...
Apr 11, 2021 | Featured, Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the numerous cost-drivers that inflate the price of American healthcare. They highlight how electronic health records requirements divert doctors’ attention away from patients to unproductive bureaucratic...
